Nonetheless, in BALB/c mice vaccinated with recombinant A2 protein or LRP plus saponin, the protection against cutaneous or visceral leishmaniasis have been also correlated with a decrease in Leishmania-specific IL-4 and IL-10 mediated response [12], [17], [22], [33]. This evidence concerns the gene IL10 and visceral leishmaniasis.